EPINEPHRINE Safety Questions, EPINEPHRINE Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about EPINEPHRINE. Our extensive database of EPINEPHRINE adverse events and EPINEPHRINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about EPINEPHRINE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




EPINEPHRINE Safety Reports

Total EPINEPHRINE reports: 69.
EPINEPHRINE FDA safety alerts: 2004 2005 2006 .
Reported deaths: 2    Reported hospitalizations: 19.
Take EPINEPHRINE Side Effects Survey or Share Your EPINEPHRINE Story. Read More Here.

Physician from UNITED STATES reported EPINEPHRINE problem on Dec 19, 2006. Female patient, 55 years of age, was diagnosed with respiratory distress and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, electrocardiogram st segment elevation, hypotension, myocardial ischaemia, ventricular tachycardia. EPINEPHRINE dosage: unknown. During the same period patient was treated with PROPOFOL, LIDOCAINE, SUCCINYLCHOLINE CHLORIDE, NITROUS OXIDE, SEVOFLURANE, FENTANYL, PROMETHAZINE, ONDANSETRON HYDROCHLORIDE. Patient recovered.

EPINEPHRINE problem was reported by a Pharmacist from CANADA on Jan 09, 2007. Male patient, child 3 years of age, was diagnosed with hypersensitivity and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure, hypersensitivity. EPINEPHRINE dosage: 0.15 MG SC. Patient recovered.

Pharmacist from CANADA reported EPINEPHRINE problem on Jan 12, 2007. Male patient, 16 years of age, was diagnosed with anaphylactic reaction, food allergy and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device malfunction. EPINEPHRINE dosage: 0.3 MG PRN SC. Patient was hospitalized. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2007. Male patient, 47 years of age, weighting 215.0 lb, was diagnosed with allergy to arthropod sting and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure, dizziness, dyspnoea. EPINEPHRINE dosage: 0.3 MG PRN SC. During the same period patient was treated with NEXIUM. Patient recovered.

Pharmacist from CANADA reported EPINEPHRINE problem on Jan 23, 2007. Female patient, 34 years of age, was diagnosed with anaphylactic reaction, food allergy and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure. EPINEPHRINE dosage: 0.3 MG UNK SC. Patient recovered.

EPINEPHRINE problem was reported by a Health Professional from CANADA on Jan 24, 2007. Male patient, 13 years of age, was diagnosed with anaphylactic reaction, hypersensitivity and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, device connection issue, food allergy. EPINEPHRINE dosage: 0.3 MG SC. Patient recovered.

Pharmacist from UNITED STATES reported EPINEPHRINE problem on Feb 06, 2007. Male patient, 30 years of age, was diagnosed with swelling face and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device leakage, device malfunction, incorrect dose administered. EPINEPHRINE dosage: 0.3 MG PRN SC. During the same period patient was treated with ALLEGRA, ZYRTEC. Patient recovered.

EPINEPHRINE problem was reported by a Health Professional from UNITED STATES on Feb 14, 2007. Female patient, 60 years of age, weighting 128.0 lb, was diagnosed with haemorrhage and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal necrosis, sepsis. EPINEPHRINE dosage: unknown. During the same period patient was treated with LEVOXYL, NEXIUM, METFORMIN, CRESTOR, FESO, CALCITRIOL, CALCIUM. Patient was hospitalized. Patient recovered.

Physician from KOREA, REPUBLIC OF reported EPINEPHRINE problem on Feb 19, 2007. Female patient was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, coma, grand mal convulsion, headache, intraventricular haemorrhage, loss of consciousness, oxygen saturation decreased, respiratory rate decreased, subarachnoid haemorrhage. EPINEPHRINE dosage: .3 ML, SINGLE. Patient died.

EPINEPHRINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2007. Female patient, 29 years of age, was diagnosed with eyelid oedema, lip swelling, respiratory distress, swelling face and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, arteriospasm coronary, extrasystoles, heart rate increased, myocardial ischaemia. EPINEPHRINE dosage: 0.1 MG/ML ONCE IV. During the same period patient was treated with DIPHENHYDRAMINE, METHYLPREDNISOLONE, CIMETIDINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported EPINEPHRINE problem on Mar 19, 2007. Male patient, 30 years of age, was diagnosed with swelling face and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device leakage, device malfunction. EPINEPHRINE dosage: 0.3 MG PRN SC. During the same period patient was treated with ALLEGRA, ZYRTEC. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 16, 2007. Male patient, 30 years of age, was diagnosed with food allergy, urticaria, wheezing and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, electrocardiogram change. EPINEPHRINE dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EPINEPHRINE problem on Mar 17, 2007. Female patient, 42 years of age, was diagnosed with hypersensitivity, throat tightness and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device malfunction, incorrect dose administered, no therapeutic response, refusal of treatment by patient. EPINEPHRINE dosage: 0.3 MG PRN SC. During the same period patient was treated with ASTELIN. Patient recovered.

EPINEPHRINE problem was reported by a Physician from UNITED STATES on Mar 16, 2007. Male patient, 43 years of age, was diagnosed with pruritus, rash and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. EPINEPHRINE dosage: 0.3 MG TWICE SC. During the same period patient was treated with AMOXICILLIN, DIPHENHYDRAMINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EPINEPHRINE problem on Mar 16, 2007. Male patient, 41 years of age, was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. EPINEPHRINE dosage: 0.5 MG ONCE SC. Patient recovered.

EPINEPHRINE problem was reported by a Pharmacist from UNITED STATES on Dec 20, 2006. Female patient was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device malfunction. EPINEPHRINE dosage: 0.3 MG ONCE SC. Patient recovered.

Health Professional from KOREA, REPUBLIC OF reported EPINEPHRINE problem on Mar 21, 2007. Male patient, 36 years of age, was diagnosed with allergy to arthropod sting, haemodynamic instability and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, grand mal convulsion, intraventricular haemorrhage, loss of consciousness, oxygen saturation decreased, subarachnoid haemorrhage. EPINEPHRINE dosage: 0.3 ML ONCE SC. Patient was hospitalized. Patient died.

EPINEPHRINE problem was reported by a Pharmacist from CANADA on Mar 23, 2007. Male patient was diagnosed with hypersensitivity and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: allergy to arthropod sting, device malfunction. EPINEPHRINE dosage: 0.3 MG. Patient recovered.

Pharmacist from UNITED STATES reported EPINEPHRINE problem on Apr 23, 2007. Male patient, 43 years of age, weighting 175.0 lb, was diagnosed with stridor and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: chest pain, ventricular tachycardia, vomiting. EPINEPHRINE dosage: 0.3MG ONCE IM. Patient was hospitalized. Patient recovered.

EPINEPHRINE problem was reported by a Physician from CANADA on Apr 05, 2007. Male patient, 18 years of age, was diagnosed with anaphylactic reaction, food allergy and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, device failure, device malfunction. EPINEPHRINE dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported EPINEPHRINE problem on Dec 19, 2006. Male patient was diagnosed with food allergy and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device malfunction, erythema. EPINEPHRINE dosage: unknown. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from FRANCE on Apr 24, 2007. Female patient, 47 years of age, was diagnosed with anaphylactic shock, hypertension and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: blood pressure immeasurable, bradycardia, nausea, pallor. EPINEPHRINE dosage: 0.1 MG, THREE TIMES IN ONE DAY, INTRAVENOUS BOLUS. During the same period patient was treated with ACEBUTOLOL, PREDNISOLONE, AMOXICILLIN, PRISTINAMYCIN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported EPINEPHRINE problem on Apr 23, 2007. Female patient, 34 years of age, was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: factitious disorder, phaeochromocytoma. EPINEPHRINE dosage: unknown. During the same period patient was treated with PHENYTOIN, LORAZEPAM, PHENOBARBITAL. Patient was hospitalized. Patient recovered.

EPINEPHRINE problem was reported by a Health Professional from UNITED STATES on Apr 23, 2007. Female patient was diagnosed with food allergy, hypersensitivity and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, device malfunction. EPINEPHRINE dosage: (0.3 MG PRN INTRAMUSCULAR). Patient recovered.

Health Professional from UNITED STATES reported EPINEPHRINE problem on Apr 27, 2007. Male patient was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device malfunction. EPINEPHRINE dosage: unknown. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from NEW ZEALAND on May 14, 2007. Female patient was diagnosed with tongue oedema and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, blood pressure systolic increased, bundle branch block right, coronary artery disease, coronary artery stenosis, electrocardiogram qt prolonged, hypotension, pulmonary oedema. EPINEPHRINE dosage: 1 MG, SINGLE. During the same period patient was treated with PARAMAX, PROMETHAZINE, HYDROCORTISONE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported EPINEPHRINE problem on May 25, 2007. Female patient, 50 years of age, weighting 120.0 lb, was diagnosed with accidental needle stick and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, injection site coldness, injection site reaction, vasoconstriction. EPINEPHRINE dosage: 0.3MG/0.3ML OTO. Patient recovered.

EPINEPHRINE problem was reported by a Pharmacist from CANADA on May 10, 2007. Female patient, weighting 30.00 lb, was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure. EPINEPHRINE dosage: unknown. During the same period patient was treated with VENTOLIN, FLOVENT. Patient recovered.

Pharmacist from CANADA reported EPINEPHRINE problem on May 15, 2007. Female patient was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure. EPINEPHRINE dosage: 0.3 MG PRN. Patient was hospitalized. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from CANADA on May 16, 2007. Female patient was diagnosed with anaphylactic reaction, latex allergy and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure, incorrect dose administered. EPINEPHRINE dosage: 0,3 MG PRN. During the same period patient was treated with NEXIUM, REACTION ALLERGY AND SINUS, DIMETAPP NIGHTTIME COLD, CLARITIN NASAL SPRAY, GABAPENTIN, NAPROXEN, AMITRIPTYLINE. Patient recovered.

Consumer or non-health professional from CANADA reported EPINEPHRINE problem on May 22, 2007. Female patient was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure, loss of consciousness, respiratory distress. EPINEPHRINE dosage: unknown. Patient was hospitalized. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from CANADA on May 22, 2007. Female patient was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, device malfunction, injection site bruising. EPINEPHRINE dosage: 0.3 MG PRN INTRAMUSCULAR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from TURKEY reported EPINEPHRINE problem on May 30, 2007. Female patient was diagnosed with gastrointestinal haemorrhage and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: amaurosis fugax, hypertensive crisis, pupillary reflex impaired, retinal exudates, retinal oedema, retinal vascular disorder. EPINEPHRINE dosage: unknown. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, 80 years of age, was diagnosed with lip swelling, swollen tongue and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: lip swelling, medical device complication, procedural complication, swollen tongue. EPINEPHRINE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EPINEPHRINE problem on June 20, 2007. Male patient, 81 years of age, was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, device failure. EPINEPHRINE dosage: unknown. During the same period patient was treated with NOREPINEPHRINE, PHENYLEPHRINE. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Male patient, 81 years of age, was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, device failure. EPINEPHRINE dosage: unknown. During the same period patient was treated with NOREPINEPHRINE, PHENYLEPHRINE. Patient recovered.

Physician from CANADA reported EPINEPHRINE problem on June 14, 2007. Male patient was diagnosed with anaphylactic reaction, food allergy and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure. EPINEPHRINE dosage: unknown. During the same period patient was treated with VENTOLIN. Patient was hospitalized. Patient recovered.

EPINEPHRINE problem was reported by a Pharmacist from UNITED STATES on Aug 10, 2006. Male patient, 72 years of age, weighting 172.0 lb, was diagnosed with cataract operation, eye irrigation and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: cataract operation complication, endophthalmitis, post procedural complication. EPINEPHRINE dosage: 1 ML IN BSS 500 ML ONCE OPHTHALMIC [ONCE]. During the same period patient was treated with CIPROFLOXACIN, TIMOLOL MALEATE, TETRACAINE POLYGYL STERILE OPHTHALMIC SOLUTION, FLURBIPROFEN, PHENYLEPHRINE, MYDRIACIL, CYCLOGEL. Patient recovered.

Pharmacist from UNITED STATES reported EPINEPHRINE problem on Aug 10, 2006. Female patient, 68 years of age, weighting 120.0 lb, was diagnosed with cataract operation and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: endophthalmitis, post procedural complication. EPINEPHRINE dosage: 1 ML IN BSS 500 ML ONCE OPHTHALMIC [ONCE]. During the same period patient was treated with CIPROFLOXACIN, TIMOLOL MALEATE, TETRACAINE POLYGYL STERILE OPHTHALMIC SOLUTION, FLURBIPROFEN, PHENYLEPHRINE, MYDRIACIL, CYCLOGEL. Patient recovered.

EPINEPHRINE problem was reported by a Pharmacist from UNITED STATES on Aug 10, 2006. Female patient, 62 years of age, weighting 210.0 lb, was diagnosed with cataract operation, eye irrigation and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: cataract operation complication, endophthalmitis, post procedural complication. EPINEPHRINE dosage: 1 ML IN BSS 500 ML ONCE OPHTHALMIC. During the same period patient was treated with CIPROFLOXACIN OPTH, TIMOLOL OPHTH, TETRACAINE OPHTH, FLURBIPROFEN OPHTH, PHENYLEPHRINE OPHTH, TROPICAMIDE OPTH, CYCLOGEL OPTH. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EPINEPHRINE problem on Aug 05, 2006. Female patient was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: hypertension, pulmonary oedema, tachycardia. EPINEPHRINE dosage: 10 ML, ONCE, INTRAVENOUS. Patient recovered.

EPINEPHRINE problem was reported by a Health Professional from UNITED STATES on Aug 05, 2006. Female patient was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: hypertension, pulmonary oedema, tachycardia. EPINEPHRINE dosage: 10 ML, ONCE, INTRAVENOUS. Patient recovered.

Physician from TAIWAN, PROVINCE OF CHINA reported EPINEPHRINE problem on Aug 28, 2006. Female patient, 77 years of age, was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: ecchymosis, gastrointestinal necrosis, injection site haemorrhage, necrosis ischaemic. EPINEPHRINE dosage: 3 ML, SINGLE. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from TURKEY on Aug 28, 2006. Male patient, 69 years of age, was diagnosed with gastrointestinal haemorrhage and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: amaurosis fugax, cerebral atrophy, eye disorder, hypertension, papilloedema, pupillary light reflex tests abnormal, pupillary reflex impaired, retinal exudates. EPINEPHRINE dosage: 16 ML, SINGLE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EPINEPHRINE problem on Sept 08, 2006. Female patient was diagnosed with eye irrigation and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: corneal transplant, ocular vascular disorder, shock, transplant failure. EPINEPHRINE dosage: unknown. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 08, 2006. Female patient was diagnosed with eye irrigation and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: corneal transplant, ocular vascular disorder, shock, transplant failure. EPINEPHRINE dosage: unknown. Patient recovered.

Physician from UNITED STATES reported EPINEPHRINE problem on Sept 08, 2006. Female patient was diagnosed with eye irrigation and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: corneal transplant, ocular vascular disorder, shock, transplant failure. EPINEPHRINE dosage: unknown. Patient recovered.

EPINEPHRINE problem was reported by a Health Professional from TURKEY on Sept 13, 2006. Male patient, 69 years of age, was diagnosed with gastrointestinal haemorrhage and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: amaurosis fugax, cerebral atrophy, gastric mucosal lesion, gastrointestinal haemorrhage, hypertension, papilloedema, pupillary reflex impaired, retinal exudates. EPINEPHRINE dosage: unknown. Patient recovered.

Physician from UNITED STATES reported EPINEPHRINE problem on Sept 19, 2006. Male patient, 73 years of age, was diagnosed with eye irrigation and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: injury corneal. EPINEPHRINE dosage: unknown. Patient recovered.

EPINEPHRINE problem was reported by a Physician from UNITED STATES on Sept 19, 2006. Male patient, 65 years of age, was diagnosed with eye irrigation and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: detached descemet's membrane, eye operation complication, injury corneal. EPINEPHRINE dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported EPINEPHRINE problem on Nov 16, 2006. Male patient, 84 years of age, was diagnosed with gastric ulcer, upper gastrointestinal haemorrhage and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: hypertension, myocardial infarction. EPINEPHRINE dosage: 7 ML OF SOLN 1:10,000 SOLN ONCE INTRALESION. During the same period patient was treated with TOPROL, SYNTHROID, IRON, DONEZEPIL. Patient was hospitalized. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2006. Male patient, 50 years of age, was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest. EPINEPHRINE dosage: unknown. Patient recovered.

Physician from UNITED STATES reported EPINEPHRINE problem on Dec 04, 2006. Female patient, 55 years of age, was diagnosed with anaphylaxis treatment, post procedural nausea and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, chest pain, electrocardiogram st segment elevation, hypotension, myocardial ischaemia, presyncope, troponin t increased, vasospasm, ventricular tachycardia. EPINEPHRINE dosage: unknown. During the same period patient was treated with ALLEGRA, PHENERGAN, FENTANYL, ZOFRAN, SCOPOLAMINE, HYDROCORTISONUM HEMISUCCINATUM, BENADRYL. Patient recovered.

EPINEPHRINE problem was reported by a Physician from UNITED STATES on Aug 21, 2006. Female patient, 40 years of age, was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure. EPINEPHRINE dosage: 0.3 MG PRN SC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EPINEPHRINE problem on June 18, 2007. Female patient, weighting 130.0 lb, was diagnosed with lip swelling, swollen tongue and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure. EPINEPHRINE dosage: unknown. Patient recovered.

EPINEPHRINE problem was reported by a Health Professional from UNITED STATES on July 03, 2007. Female patient was diagnosed with hypersensitivity and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, hypersensitivity, incorrect dose administered. EPINEPHRINE dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CANADA reported EPINEPHRINE problem on July 23, 2007. Female patient, weighting 125.0 lb, was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure. EPINEPHRINE dosage: (0.3 MG INTRAMUSCULAR/SUBCUTANEOUS). During the same period patient was treated with VENTOLIN, PULMICORT. Patient recovered.

EPINEPHRINE problem was reported by a Health Professional from UNITED STATES on Aug 14, 2007. Female patient, 40 years of age, weighting 220.0 lb, was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: angioedema, chest pain, dysphagia, dyspnoea, electrocardiogram abnormal, electrocardiogram st segment elevation, ventricular tachycardia. EPINEPHRINE dosage: 1MG IV. Patient was hospitalized. Patient recovered.

Pharmacist from CANADA reported EPINEPHRINE problem on July 30, 2007. Female patient was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, device failure. EPINEPHRINE dosage: 0.03 MG INATRAMUSCULAR/SUBCUTANEOUS. During the same period patient was treated with SINGULAIR, ADVAIR DISKUS, BRICANYL. Patient recovered.

EPINEPHRINE problem was reported by a Pharmacist from CANADA on Aug 09, 2007. Male patient was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, device breakage. EPINEPHRINE dosage: 0.3 MG INTRAMUSCULAR/SUBCUTANEOUS. During the same period patient was treated with VENTOLIN. Patient recovered.

Pharmacist from UNITED STATES reported EPINEPHRINE problem on Aug 24, 2007. Female patient, 37 years of age, was diagnosed with overdose and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: convulsion, headache, hypertension, incorrect dose administered, loss of consciousness, muscular weakness, ventricular tachycardia. EPINEPHRINE dosage: unknown. Patient recovered.

EPINEPHRINE problem was reported by a Pharmacist from UNITED STATES on Aug 24, 2007. Female patient, 28 years of age, was diagnosed with hypersensitivity and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: cardiac enzymes increased, vasospasm. EPINEPHRINE dosage: 0.5ML ONE TIME IV BOLUS. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EPINEPHRINE problem on Aug 20, 2007. Female patient was diagnosed with local anaesthesia, scan lymph nodes and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: paralysis, respiratory arrest. EPINEPHRINE dosage: unknown. During the same period patient was treated with LIDOCAINE, MIDAZOLAM, FENTANYL, PROPOFOL, SEVOFLURANE, CEPHALOZOLIN, METOCLOPRAMIDE, LYMPHAZURIN. Patient recovered.

EPINEPHRINE problem was reported by a Physician from UNITED STATES on Aug 16, 2007. Female patient, weighting 138.0 lb, was diagnosed with hypersensitivity and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, device malfunction. EPINEPHRINE dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from CANADA reported EPINEPHRINE problem on Aug 24, 2007. Female patient was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure. EPINEPHRINE dosage: 0.3 MG INTRAMUSCULAR/SUBCUTANEOUS. During the same period patient was treated with MOGADON. Patient recovered.

EPINEPHRINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 27, 2007. Male patient, weighting 118.0 lb, was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device malfunction. EPINEPHRINE dosage: (0.3 MG INTRAMUSCULAR/SUBCUTANEOUS). During the same period patient was treated with ANTIHISTAMINES. Patient recovered.

Physician from UNITED STATES reported EPINEPHRINE problem on Sept 06, 2007. Female patient was diagnosed with local anaesthesia and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: hypertension, paralysis, respiratory arrest, respiratory depression, tachycardia. EPINEPHRINE dosage: 5 ML, SINGLE. During the same period patient was treated with LIDOCAINE, RADIOACTIVE MATERIAL, MIDAZOLAM, FENTANYL, PROPOFOL, SEVOFLURANE, CEPHALOZOLIN, METOCLOPRAMIDE. Patient recovered.

EPINEPHRINE problem was reported by a Health Professional from UNITED STATES on Sept 13, 2007. Female patient, weighting 240.0 lb, was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: medical device complication. EPINEPHRINE dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported EPINEPHRINE problem on Sept 10, 2007. Male patient was diagnosed with anaphylactic reaction and was treated with EPINEPHRINE. After drug was administered, patient experienced the following problems/side effects: device failure. EPINEPHRINE dosage: (0.3 MG INTRAMUSCULAR). Patient recovered.

Ask Our Patient Community about EPINEPHRINE

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon